太龙药业: 董事会战略与发展委员会实施细则

General Overview - The company aims to enhance its ESG performance and core competitiveness through strategic development and investment decision-making processes [1][2] - The Strategic and Development Committee is established under the board of directors to research and propose suggestions on long-term development strategies, major investment decisions, and ESG governance [1][2] Committee Composition - The Strategic and Development Committee consists of three directors appointed by the board [3] - The chairman of the committee is the company’s chairman, responsible for convening and presiding over committee meetings [3][4] Responsibilities and Authority - The committee's main responsibilities include researching and proposing suggestions on long-term development strategies, major investments, capital operations, and significant ESG matters [2][4] - The committee is also tasked with evaluating and supervising the implementation of these matters and reporting to the board [2][4] Meeting Procedures - The committee is required to hold at least one regular meeting annually, with additional meetings convened as necessary [4][5] - Meetings can be conducted in person or through other means, ensuring all members can express their opinions [4][5] Voting and Documentation - A quorum of two-thirds of the committee members is required for meetings to proceed, and decisions must be approved by a majority [5] - Meeting records must be kept for at least ten years, and confidentiality regarding meeting discussions is mandatory for all participants [5]